143 related articles for article (PubMed ID: 33230429)
41. A novel therapeutic drug for colon cancer: EpCAM scFv-truncated protamine (tp)-siRNA.
Hao H; Zhen Y; Wang Z; Chen F; Xie X
Cell Biol Int; 2013 Aug; 37(8):860-4. PubMed ID: 23576466
[TBL] [Abstract][Full Text] [Related]
42. Targeting Cancer Cells Using LNA-Modified Aptamer-siRNA Chimeras.
Subramanian N; Kanwar JR; Kanwar RK; Krishnakumar S
Nucleic Acid Ther; 2015 Dec; 25(6):317-22. PubMed ID: 26334953
[TBL] [Abstract][Full Text] [Related]
43. Enhancement of the productivity of free dihomo-γ-linolenic acid via co-overexpression of elongase and two desaturase genes in Aspergillus oryzae.
Tamano K; Yasunaka Y; Kamishima M; Itoh A; Miura A; Kan E; Koyama Y; Tamura T
J Biosci Bioeng; 2020 Nov; 130(5):480-488. PubMed ID: 32800811
[TBL] [Abstract][Full Text] [Related]
44. Vascular responses to the monoenoic prostaglandin precursor dihomo-gamma-linolenic acid in the perfused canine lung.
Wicks TC; Ramwell PW; Rose JC; Kot PA
J Pharmacol Exp Ther; 1977 May; 201(2):417-20. PubMed ID: 859105
[TBL] [Abstract][Full Text] [Related]
45. Tumor-targeted Nanoparticle Delivery of HuR siRNA Inhibits Lung Tumor Growth
Muralidharan R; Babu A; Amreddy N; Srivastava A; Chen A; Zhao YD; Kompella UB; Munshi A; Ramesh R
Mol Cancer Ther; 2017 Aug; 16(8):1470-1486. PubMed ID: 28572169
[TBL] [Abstract][Full Text] [Related]
46. siRNA-induced TRAF6 knockdown promotes the apoptosis and inhibits the invasion of human lung cancer SPC-A1 cells.
He Z; Huang C; Lin G; Ye Y
Oncol Rep; 2016 Apr; 35(4):1933-40. PubMed ID: 26847475
[TBL] [Abstract][Full Text] [Related]
47. Mechanism of three-component collision to produce ultrastable pRNA three-way junction of Phi29 DNA-packaging motor by kinetic assessment.
Binzel DW; Khisamutdinov E; Vieweger M; Ortega J; Li J; Guo P
RNA; 2016 Nov; 22(11):1710-1718. PubMed ID: 27672132
[TBL] [Abstract][Full Text] [Related]
48. Construction of DGLA producing cell factory by genetic modification of Mucor circinelloides.
Khan MAK; Yang J; Hussain SA; Zhang H; Liang L; Garre V; Song Y
Microb Cell Fact; 2019 Apr; 18(1):64. PubMed ID: 30943965
[TBL] [Abstract][Full Text] [Related]
49. Anti-EpCAM-conjugated adeno-associated virus serotype 2 for systemic delivery of EGFR shRNA: Its retargeting and antitumor effects on OVCAR3 ovarian cancer in vivo.
Lee S; Ahn HJ
Acta Biomater; 2019 Jun; 91():258-269. PubMed ID: 31026519
[TBL] [Abstract][Full Text] [Related]
50. Epithelial cell adhesion molecule overexpression regulates epithelial-mesenchymal transition, stemness and metastasis of nasopharyngeal carcinoma cells via the PTEN/AKT/mTOR pathway.
Wang MH; Sun R; Zhou XM; Zhang MY; Lu JB; Yang Y; Zeng LS; Yang XZ; Shi L; Xiao RW; Wang HY; Mai SJ
Cell Death Dis; 2018 Jan; 9(1):2. PubMed ID: 29305578
[TBL] [Abstract][Full Text] [Related]
51. Lentivirus-mediated shRNA interference targeting cyclooxygenase-2 inhibits growth of human non-small cell lung cancer.
Li T; Lu J; Zhong Y
J BUON; 2013; 18(4):908-14. PubMed ID: 24344016
[TBL] [Abstract][Full Text] [Related]
52. Distribution and metabolism of dihomo-gamma-linolenic acid (DGLA, 20:3n-6) by oral supplementation in rats.
Umeda-Sawada R; Fujiwara Y; Ushiyama I; Sagawa S; Morimitsu Y; Kawashima H; Ono Y; Kiso Y; Matsumoto A; Seyama Y
Biosci Biotechnol Biochem; 2006 Sep; 70(9):2121-30. PubMed ID: 16960355
[TBL] [Abstract][Full Text] [Related]
53. EpCAM is overexpressed in breast cancer and is a potential target for breast cancer gene therapy.
Osta WA; Chen Y; Mikhitarian K; Mitas M; Salem M; Hannun YA; Cole DJ; Gillanders WE
Cancer Res; 2004 Aug; 64(16):5818-24. PubMed ID: 15313925
[TBL] [Abstract][Full Text] [Related]
54. In vitro and in vivo evaluation of therapy targeting epithelial-cell adhesion-molecule aptamers for non-small cell lung cancer.
Alibolandi M; Ramezani M; Abnous K; Sadeghi F; Atyabi F; Asouri M; Ahmadi AA; Hadizadeh F
J Control Release; 2015 Jul; 209():88-100. PubMed ID: 25912964
[TBL] [Abstract][Full Text] [Related]
55. Induction of apoptosis in non-small cell lung cancer by downregulation of MDM2 using pH-responsive PMPC-b-PDPA/siRNA complex nanoparticles.
Yu H; Zou Y; Jiang L; Yin Q; He X; Chen L; Zhang Z; Gu W; Li Y
Biomaterials; 2013 Apr; 34(11):2738-47. PubMed ID: 23352573
[TBL] [Abstract][Full Text] [Related]
56. Metabolic engineering of long chain-polyunsaturated fatty acid biosynthetic pathway in oleaginous fungus for dihomo-gamma linolenic acid production.
Chutrakul C; Jeennor S; Panchanawaporn S; Cheawchanlertfa P; Suttiwattanakul S; Veerana M; Laoteng K
J Biotechnol; 2016 Jan; 218():85-93. PubMed ID: 26686314
[TBL] [Abstract][Full Text] [Related]
57. Ku80 cooperates with CBP to promote COX-2 expression and tumor growth.
Xiao Y; Wang J; Qin Y; Xuan Y; Jia Y; Hu W; Yu W; Dai M; Li Z; Yi C; Zhao S; Li M; Du S; Cheng W; Xiao X; Chen Y; Wu T; Meng S; Yuan Y; Liu Q; Huang W; Guo W; Wang S; Deng W
Oncotarget; 2015 Apr; 6(10):8046-61. PubMed ID: 25797267
[TBL] [Abstract][Full Text] [Related]
58. Epithelial cell adhesion molecule (EpCAM) is involved in prostate cancer chemotherapy/radiotherapy response in vivo.
Ni J; Cozzi P; Beretov J; Duan W; Bucci J; Graham P; Li Y
BMC Cancer; 2018 Nov; 18(1):1092. PubMed ID: 30419852
[TBL] [Abstract][Full Text] [Related]
59. In vivo tumor targeting via nanoparticle-mediated therapeutic siRNA coupled to inflammatory response in lung cancer mouse models.
Conde J; Tian F; Hernández Y; Bao C; Cui D; Janssen KP; Ibarra MR; Baptista PV; Stoeger T; de la Fuente JM
Biomaterials; 2013 Oct; 34(31):7744-53. PubMed ID: 23850099
[TBL] [Abstract][Full Text] [Related]
60. HDAC inhibition activates the apoptosome via Apaf1 upregulation in hepatocellular carcinoma.
Buurman R; Sandbothe M; Schlegelberger B; Skawran B
Eur J Med Res; 2016 Jun; 21(1):26. PubMed ID: 27342975
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
